Abstract
Background
Pulmonary hypertension complicates the clinical course of extremely preterm infants and is associated with bronchopulmonary dysplasia (BPD). However, prevalence, risk factors, and outcome of pulmonary hypertension in these infants are insufficiently known. This systematic review and meta-analysis aims to provide an up-to-date overview of available data on prevalence, risk factors, and outcome of pulmonary hypertension and to identify current knowledge gaps.Methods
Medline, EMBASE, and the Cochrane Library databases were searched in July 2017. Two authors reviewed titles/abstracts and full-texts. Eligible studies reported prevalence, patient characteristics or mortality of infants with/without pulmonary hypertension. Studies were excluded if they did not include extremely preterm infants. Only similar study samples (selected infants with BPD or infants both with/without BPD) were compared in the meta-analyses.Results
Of 1829 unique articles identified, 25 were eligible for inclusion. Pulmonary hypertension was observed in infants with BPD (20%, 95% confidence interval [CI] 14, 25), but also in those without BPD (2%, 95% CI 0, 8). Infants with severe BPD were most at risk of pulmonary hypertension (risk ratio [RR] 2.7, 95% CI 1.7, 4.2). Infants with pulmonary hypertension were more at risk of mortality (RR 4.7, 95% CI 2.7, 8.3).Conclusions
Pulmonary hypertension occurs in particularly in infants with severe BPD, and increases risk of mortality. Due to selected study populations, heterogeneous pulmonary hypertension-definitions and poorly reported timing of pulmonary hypertension assessments, however, data available in current reports are insufficient to allow accurate assessment of true prevalence, risk factors, and time-related outcome. Prospective studies, with standardised methodology and follow-up are needed to determine these factors.Full text links
Read article at publisher's site: https://doi.org/10.1111/ppe.12444
Read article for free, from open access legal sources, via Unpaywall: https://pure.rug.nl/ws/files/54250980/Arjaans_et_al_2018_Paediatric_and_Perinatal_Epidemiology.pdf
References
Articles referenced by this article (50)
Definitions and diagnostic criteria for bronchopulmonary dysplasia.
Semin Perinatol, (4):164-170 2006
MED: 16860155
Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.
N Engl J Med, (7):357-368 1967
MED: 5334613
Clinical features of paediatric pulmonary hypertension: a registry study.
Lancet, (9815):537-546 2012
MED: 22240409
Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.
Am J Respir Crit Care Med, (1):87-95 2015
MED: 25389562
Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era.
Pediatrics, (6):1260-1269 2007
MED: 18055675
Prospective analysis of pulmonary hypertension in extremely low birth weight infants.
Pediatrics, (3):e682-9 2012
MED: 22311993
Impact of a physiologic definition on bronchopulmonary dysplasia rates.
Pediatrics, (5):1305-1311 2004
MED: 15520112
Patient characteristics in persistent pulmonary hypertension of the newborn.
Pulm Med, 858154 2011
MED: 21660250
Chronic lung disease in the preterm infant. Lessons learned from animal models.
Am J Respir Cell Mol Biol, (2):233-245 2014
MED: 24024524
Show 10 more references (10 of 50)
Citations & impact
Impact metrics
Article citations
Achieved oxygen saturations and risk for bronchopulmonary dysplasia with pulmonary hypertension in preterm infants.
Arch Dis Child, 109(11):941-947, 18 Oct 2024
Cited by: 0 articles | PMID: 38937062 | PMCID: PMC11503043
Outcomes of infants and children with bronchopulmonary dysplasia-associated pulmonary hypertension who required home ventilation.
Pediatr Res, 24 Aug 2024
Cited by: 0 articles | PMID: 39181986
Patent Ductus Arteriosus and Lung Magnetic Resonance Imaging Phenotype in Moderate and Severe Bronchopulmonary Dysplasia-Pulmonary Hypertension.
Am J Respir Crit Care Med, 210(3):318-328, 01 Aug 2024
Cited by: 1 article | PMID: 38568735
Home is where the right ventricle lives: bronchopulmonary dysplasia-associated pulmonary hypertension and home ventilation.
Pediatr Res, 12 Sep 2024
Cited by: 0 articles | PMID: 39266628
Navigating Diagnostic and Treatment Challenges of Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia.
J Clin Med, 13(12):3417, 11 Jun 2024
Cited by: 0 articles | PMID: 38929946
Review
Go to all (74) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
The Impact of Atrial Left-to-Right Shunt on Pulmonary Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia.
Pediatr Neonatol, 56(5):317-323, 12 Feb 2015
Cited by: 27 articles | PMID: 26328892
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Cochrane Database Syst Rev, 2(2022), 01 Feb 2022
Cited by: 12 articles | PMID: 36321557 | PMCID: PMC8805585
Review Free full text in Europe PMC
Pulmonary hypertension in extremely preterm infants: a call to standardize echocardiographic screening and follow-up policy.
Eur J Pediatr, 180(6):1855-1865, 02 Feb 2021
Cited by: 6 articles | PMID: 33528615 | PMCID: PMC8105237
Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Cochrane Database Syst Rev, 8:CD002311, 24 Aug 2017
Cited by: 27 articles | PMID: 28836266 | PMCID: PMC6483527
Review Free full text in Europe PMC